Lexicon Pharmaceuticals Announces Publication of Positive Data for Zynquista™ (Sotagliflozin) on Cardiorenal Clinical Biomarkers in Adults With Type 1 Diabetes August 8, 2019 - NASDAQ Companies 0 » View More News for August 08, 2019